Apic Bio is a gene therapy company that is engaged in finding cures for patients with devastating neurological and liver genetic diseases. The Company's pipeline focuses on treatments for Alpha-1 Antitrypsin Deficiency (Alpha-1, or AATD) and genetic Amyotrophic Lateral Sclerosis (ALS).